Evaluation of a low cost cryopreservation system on the biology of human amniotic fluid-derived mesenchymal stromal cells

Cryobiology

Volumn 64, Issue 3, 2012, Pages 160-166

  Miranda Sayago, Jose Maria ^a,b   Fernandez Arcas, Nieves ^a,b   Benito, Carmen ^a   Reyes Engel, Armando ^b   Herrero, Jose Ramon ^a   Alonso, Antonio ^a,b  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b UNIVERSIDAD DE MÁLAGA   (Spain)

Author keywords

Amniotic fluid derived mesenchymal stromal cells; Cell banking; Cryopreservation; Differentiation; DMSO; Longevity

Indexed keywords

AMNIOTIC FLUID CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CRYOPRESERVATION; CRYOPROTECTION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; KARYOTYPING; MESENCHYMAL STEM CELL; PRIORITY JOURNAL;

AMNIOTIC FLUID; BIOLOGICAL SPECIMEN BANKS; CELL COUNT; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CRYOPRESERVATION; CRYOPROTECTIVE AGENTS; DIMETHYL SULFOXIDE; HUMANS; IMMUNOPHENOTYPING; KARYOTYPING; MESENCHYMAL STROMAL CELLS;

EID: 84861230869     PISSN: 00112240     EISSN: 10902392     Source Type: Journal    
DOI: 10.1016/j.cryobiol.2012.01.003     Document Type: Article

References (44)

1. Nadler H.L. Prenatal detection of genetic defects. J. Pediatr. 1969, 74(1):132-143.
2. Prusa A.R., Marton E., Rosner M., Bernaschek G., Hengstschlager M. Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research?. Hum. Reprod. 2003, 18(7):1489-1493.
3. De Coppi P., Bartsch G., Siddiqui M.M., Xu T., Santos C.C., Perin L., et al. Isolation of amniotic stem cell lines with potential for therapy. Nat. Biotechnol. 2007, 25(1):100-106.
4. Hampton T. Stem cells obtained from amniotic fluid. JAMA 2007, 297(8):795.
5. Kaviani A., Guleserian K., Perry T.E., Jennings R.W., Ziegler M.M., Fauza D.O. Fetal tissue engineering from amniotic fluid. J. Am. Coll. Surg. 2003, 196(4):592-597.
6. Pan H.C., Yang D.Y., Chiu Y.T., Lai S.Z., Wang Y.C., Chang M.H., et al. Enhanced regeneration in injured sciatic nerve by human amniotic mesenchymal stem cell. J. Clin. Neurosci. 2006, 13(5):570-575.
7. Walther G., Gekas J., Bertrand O.F. Amniotic stem cells for cellular cardiomyoplasty: promises and premises. Catheter Cardiovasc. Interv. 2009, 73(7):917-924.
8. Da Sacco S., Sedrakyan S., Boldrin F., Giuliani S., Parnigotto P., Habibian R., et al. Human amniotic fluid as a potential new source of organ specific precursor cells for future regenerative medicine applications. J. Urol. 2010, 183(3):1193-1200.
9. Kim J., Lee Y., Kim H., Hwang K.J., Kwon H.C., Kim S.K., et al. Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. Cell Prolif. 2007, 40(1):75-90.
10. Bossolasco P., Montemurro T., Cova L., Zangrossi S., Calzarossa C., Buiatiotis S., et al. Molecular and phenotypic characterization of human amniotic fluid cells and their differentiation potential. Cell Res. 2006, 16(4):329-336.
11. Miranda-Sayago J.M., Fernandez-Arcas N., Benito C., Reyes-Engel A., Carrera J., Alonso A. Lifespan of human amniotic fluid-derived multipotent mesenchymal stromal cells. Cytotherapy 2011, 13(5):572-581.
12. Hanna J., Hubel A. Preservation of stem cells. Organogenesis 2009, 5(3):134-137.
13. Thirumala S., Zvonic S., Floyd E., Gimble J.M., Devireddy R.V. Effect of various freezing parameters on the immediate post-thaw membrane integrity of adipose tissue derived adult stem cells. Biotechnol. Prog. 2005, 21(5):1511-1524.
14. Loutradi K.E., Kolibianakis E.M., Venetis C.A., Papanikolaou E.G., Pados G., Bontis I., et al. Cryopreservation of human embryos by vitrification or slow freezing: a systematic review and meta-analysis. Fertil. Steril. 2008, 90(1):186-193.
15. Mazur P. The role of intracellular freezing in the death of cells cooled at supraoptimal rates. Cryobiology 1977, 14(3):251-272.
16. Fahy G.M. Vitrification: a new approach to organ cryopreservation. Prog. Clin. Biol. Res. 1986, 224:305-335.
17. Isachenko V., Isachenko E., Weiss J.M. Human ovarian tissue: vitrification versus conventional freezing. Hum. Reprod. 2009, 24(7):1767-1768. Author reply 1768-9.
18. Woods E.J., Benson J.D., Agca Y., Critser J.K. Fundamental cryobiology of reproductive cells and tissues. Cryobiology 2004, 48(2):146-156.
19. Vajta G., Nagy Z.P. Are programmable freezers still needed in the embryo laboratory? Review on vitrification. Reprod. Biomed. Online 2006, 12(6):779-796.
20. Todorov P., Hristova E., Konakchieva R., Michova A., Dimitrov J. Comparative studies of different cryopreservation methods for mesenchymal stem cells derived from human fetal liver. Cell Biol. Int. 2010, 34(5):455-462.
21. Moon J.H., Lee J.R., Jee B.C., Suh C.S., Kim S.H., Lim H.J., et al. Successful vitrification of human amnion-derived mesenchymal stem cells. Hum. Reprod. 2008, 23(8):1760-1770.
22. Carvalho K.A., Cury C.C., Oliveira L., Cattaned R.I., Malvezzi M., Francisco J.C., et al. Evaluation of bone marrow mesenchymal stem cell standard cryopreservation procedure efficiency. Transplant Proc. 2008, 40(3):839-841.
23. Gonda K., Shigeura T., Sato T., Matsumoto D., Suga H., Inoue K., et al. Preserved proliferative capacity and multipotency of human adipose-derived stem cells after long-term cryopreservation. Plast Reconstr. Surg. 2008, 121(2):401-410.
24. Darzynkiewicz Z., Bruno S., Del Bino G., Gorczyca W., Hotz M.A., Lassota P., et al. Features of apoptotic cells measured by flow cytometry. Cytometry 1992, 13(8):795-808.
25. Fox M.H. A model for the computer analysis of synchronous DNA distributions obtained by flow cytometry. Cytometry 1980, 1(1):71-77.
26. Wei J.P., Nawata M., Wakitani S., Kametani K., Ota M., Toda A., et al. Human amniotic mesenchymal cells differentiate into chondrocytes. Cloning Stem Cells 2009, 11(1):19-26.
27. Fernandez-Arcas N., Blanco A., Gaitan M.J., Nyqvist M., Alonso A., Reyes-Engel A. Differential transcriptional expresion of the polymorphic myxovirus resistance protein A in response to interferon-alpha treatment. Pharmacogenetics 2004, 14(3):189-193.
28. Oreffo R.O., Cooper C., Mason C., Clements M. Mesenchymal stem cells: lineage, plasticity, and skeletal therapeutic potential. Stem Cell Rev. 2005, 1(2):169-178.
29. Sell S. Adult stem cell plasticity: introduction to the first issue of stem cell reviews. Stem Cell Rev. 2005, 1(1):1-7.
30. Phinney D.G., Prockop D.J. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Stem Cells 2007, 25(11):2896-2902.
31. Kunisaki S.M., Armant M., Kao G.S., Stevenson K., Kim H., Fauza D.O. Tissue engineering from human mesenchymal amniocytes: a prelude to clinical trials. J. Pediatr. Surg. 2007, 42(6):974-979. Discussion 979-80.
32. Mareschi K., Rustichelli D., Comunanza V., De Fazio R., Cravero C., Morterra G., et al. Multipotent mesenchymal stem cells from amniotic fluid originate neural precursors with functional voltage-gated sodium channels. Cytotherapy 2009, 11(5):534-547.
33. Cananzi M., Atala A., De Coppi P. Stem cells derived from amniotic fluid: new potentials in regenerative medicine. Reprod. Biomed. Online 2009, 18(Suppl 1):17-27.
34. Kaviani A., Perry T.E., Dzakovic A., Jennings R.W., Ziegler M.M., Fauza D.O. The amniotic fluid as a source of cells for fetal tissue engineering. J. Pediatr. Surg. 2001, 36(11):1662-1665.
35. Thirumala S., Goebel W.S., Woods E.J. Clinical grade adult stem cell banking. Organogenesis 2009, 5(3):143-154.
36. Diaferia G.R., Dessi S.S., Deblasio P., Biunno I. Is stem cell chromosomes stability affected by cryopreservation conditions?. Cytotechnology 2008, 58(1):11-16.
37. Davis J.M., Rowley S.D., Braine H.G., Piantadosi S., Santos G.W. Clinical toxicity of cryopreserved bone marrow graft infusion. Blood 1990, 75(3):781-786.
38. Ruiz-Delgado G.J., Mancias-Guerra C., Tamez-Gomez E.L., Rodriguez-Romo L.N., Lopez-Otero A., Hernandez-Arizpe A., et al. Dimethyl sulfoxide-induced toxicity in cord blood stem cell transplantation: report of three cases and review of the literature. Acta Haematol. 2009, 122(1):1-5.
39. Stroncek D.F., Fautsch S.K., Lasky L.C., Hurd D.D., Ramsay N.K., McCullough J. Adverse reactions in patients transfused with cryopreserved marrow. Transfusion 1991, 31(6):521-526.
40. Iwatani M., Ikegami K., Kremenska Y., Hattori N., Tanaka S., Yagi S., et al. Dimethyl sulfoxide has an impact on epigenetic profile in mouse embryoid body. Stem Cells 2006, 24(11):2549-2556.
41. Li E. Chromatin modification and epigenetic reprogramming in mammalian development. Nat. Rev. Genet. 2002, 3(9):662-673.
42. Preisler H.D., Giladi M. Differentiation of erythroleukemic cells in vitro: irreversible induction by dimethyl sulfoxide (DMSO). J. Cell Physiol. 1975, 85(3):537-546.
43. Edwards M.K., Harris J.F., McBurney M.W. Induced muscle differentiation in an embryonal carcinoma cell line. Mol. Cell Biol. 1983, 3(12):2280-2286.
44. Woodbury D., Kramer B.C., Reynolds K., Marcus A.J., Coyne T.M., Black I.B. Long-term cryopreserved amniocytes retain proliferative capacity and differentiate to ectodermal and mesodermal derivatives in vitro. Mol. Reprod. Dev. 2006, 73(11):1463-1472.